标题
Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms
作者
关键词
-
出版物
Expert Review of Vaccines
Volume 13, Issue 7, Pages 873-883
出版商
Informa UK Limited
发表日期
2014-05-23
DOI
10.1586/14760584.2014.922416
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Avian influenza viruses in humans
- (2016) J.S. MALIK PEIRIS REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
- Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization
- (2014) Surender Khurana et al. PLoS One
- DNA Priming Prior to Inactivated Influenza A(H5N1) Vaccination Expands the Antibody Epitope Repertoire and Increases Affinity Maturation in a Boost-Interval–Dependent Manner in Adults
- (2013) Surender Khurana et al. JOURNAL OF INFECTIOUS DISEASES
- Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
- (2013) Julie E. Ledgerwood, Kathryn Zephir, Zonghui Hu, Chih-Jen Wei, LeeJah Chang, Mary E. Enama, Cynthia S. Hendel, Sandra Sitar, Robert T. Bailer, Richard A. Koup, John R. Mascola, Gary J. Nabel, Barney S. Graham et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
- (2013) Marc Gurwith et al. LANCET INFECTIOUS DISEASES
- Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
- (2013) Richard D Antrobus et al. MOLECULAR THERAPY
- Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
- (2013) Timothy J. Powell et al. PLoS One
- Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination
- (2013) S.-E. Bentebibel et al. Science Translational Medicine
- The prospects and challenges of universal vaccines for influenza
- (2013) Kanta Subbarao et al. TRENDS IN MICROBIOLOGY
- Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines
- (2013) Wayne C. Koff et al. VACCINE
- Phase I/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1
- (2013) Christina Mössler et al. VACCINE
- H5N1 vaccines in humans
- (2013) Mariana Baz et al. VIRUS RESEARCH
- Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study
- (2013) Lone Simonsen et al. PLOS MEDICINE
- New World Bats Harbor Diverse Influenza A Viruses
- (2013) Suxiang Tong et al. PLoS Pathogens
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
- (2012) Patrick J. Lillie et al. CLINICAL INFECTIOUS DISEASES
- Prime–boost approaches to tuberculosis vaccine development
- (2012) Neha Dalmia et al. Expert Review of Vaccines
- Pseudotyped Influenza A Virus as a Vaccine for the Induction of Heterotypic Immunity
- (2012) T. J. Powell et al. JOURNAL OF VIROLOGY
- Effect of Priming with H1N1 Influenza Viruses of Variable Antigenic Distances on Challenge with 2009 Pandemic H1N1 Virus
- (2012) Christopher D. O'Donnell et al. JOURNAL OF VIROLOGY
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study
- (2012) Fatimah S Dawood et al. LANCET INFECTIOUS DISEASES
- A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine
- (2012) Robert B. Couch et al. PLoS One
- A distinct lineage of influenza A virus from bats
- (2012) S. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Overlapping Protein-Coding Region in Influenza A Virus Segment 3 Modulates the Host Response
- (2012) B. W. Jagger et al. SCIENCE
- Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming
- (2012) Maikel V.W. van der Velden et al. VACCINE
- Influenza viruses
- (2012) Leslie A. Reperant et al. Human Vaccines & Immunotherapeutics
- Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin
- (2011) Saleem Basha et al. HUMAN IMMUNOLOGY
- Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant
- (2011) Robert B. Belshe et al. JOURNAL OF INFECTIOUS DISEASES
- Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
- (2011) Daniel F. Hoft et al. JOURNAL OF INFECTIOUS DISEASES
- H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans
- (2011) S. Khurana et al. JOURNAL OF VIROLOGY
- DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
- (2011) Julie E Ledgerwood et al. LANCET INFECTIOUS DISEASES
- An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus
- (2011) Yasuko Hatta et al. VACCINE
- Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses
- (2011) Paula A. Lanthier et al. VACCINE
- Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine
- (2011) Paul A. Tambyah et al. VACCINE
- Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
- (2010) Robert M Paris et al. Expert Review of Vaccines
- Prime-boost vectored malaria vaccines: Progress and prospects
- (2010) Adrian V. S. Hill et al. Human vaccines & immunotherapeutics
- Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
- (2010) Richard A. Koup et al. PLoS One
- Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
- (2010) Nathalie Landry et al. PLoS One
- Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
- (2010) C.-J. Wei et al. SCIENCE
- Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin
- (2010) Larry R. Smith et al. VACCINE
- H5N1 influenza viruses: outbreaks and biological properties
- (2009) Gabriele Neumann et al. CELL RESEARCH
- A Cell Culture (Vero)–Derived H5N1 Whole‐Virus Vaccine Induces Cross‐Reactive Memory Responses
- (2009) Hartmut J. Ehrlich et al. JOURNAL OF INFECTIOUS DISEASES
- A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication‐Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1
- (2009) Volker Wacheck et al. JOURNAL OF INFECTIOUS DISEASES
- Comparative Cell‐Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV‐1 Clade BgagVaccine Prime‐Boost Regimens
- (2009) David M. Asmuth et al. JOURNAL OF INFECTIOUS DISEASES
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
- (2009) Kathy Hancock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine
- (2009) Julia Romanova et al. PLoS One
- Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of a live-attenuated influenza B ΔNS1 intranasal vaccine candidate
- (2009) Nina Wressnigg et al. VACCINE
- Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults
- (2009) Ruth A. Karron et al. VACCINE
- A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
- (2009) Rebecca J. Cox et al. VACCINE
- Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
- (2008) M. Keith Howard et al. BIOLOGICAL CHEMISTRY
- Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children
- (2008) B. D. Forrest et al. Clinical and Vaccine Immunology
- Evaluation of the Safety and Immunogenicity of a Booster (Third) Dose of Inactivated Subvirion H5N1 Influenza Vaccine in Humans
- (2008) Kenneth M. Zangwill et al. JOURNAL OF INFECTIOUS DISEASES
- Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine after Priming with an Antigenic Variant
- (2008) Nega Ali Goji et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody Persistence after 2‐Dose Priming and Booster Response to a Third Dose of an Inactivated, Adjuvanted, Whole‐Virion H5N1 Vaccine
- (2008) Jiang‐Tao Lin et al. JOURNAL OF INFECTIOUS DISEASES
- Update on Avian Influenza A (H5N1) Virus Infection in Humans
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
- (2008) Hartmut J. Ehrlich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
- (2008) Rick A. Bright et al. PLoS One
- Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses
- (2008) Sanae Sasaki et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started